Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Aurora Cannabis

Canopy Growth

Cronos Group

Marijuana stocks were battered in 2022 along with all the other growth names, which means they're set for a big rebound. Ben Rains can get you prepared for a burgeoning space that grows more profitable and more legal every day.

Marijuana Sales Are Soaring and the Sky's the Limit

Cannabis stocks are drawing interest on speculation that regulation may soon replace prohibition of marijuana. Tilray (NASDAQ: TLRY ), Aurora Cannabis (NASDAQ: ACB ) and Canopy Growth (NASDAQ: CGC ) all rose sharply Dec. 1.

Cannabis Stocks TLRY, ACB, CGC Have a Huge Catalyst Before 2023

TLRY has gained momentum, rallying since the company's Q3 earnings report, and approaching a 7-month high. The cannabis sector has been crushed all year, although Tilray maintains a positive long-term outlook as a global leader.

Tilray Brands: Legalization In Germany Is The Next Growth Driver

Kinross Gold

Transocean

It's not just crypto winter that has many investors down. The year has also been gloomy for most penny stocks.

3 Penny Stocks to Take Seriously in 2023

Are Canadian Pot Stocks Setting Up For 2023? The post Top Canadian Marijuana Stocks To Buy? 2 For List In December appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Marijuana Stocks To Buy? 2 For List In December

Both companies have solid fundamentals, but one has a greater potential to soar.

Better Growth Stock: Tilray vs Cresco Labs

AppHarvest

Borr Drilling Ltd

Riot Blockchain

Solid Power

Electrameccanica

There was no dearth of multibagger penny stocks in 2021. However, 2022 has been a year to forget when it comes to returns from penny stocks.

7 Multibagger Penny Stocks to Buy in November

Legal barriers are falling, and the North American market is set to be in flux.

3 Big Changes Could Be Coming for Cannabis Stocks Before 2024

DoorDash

These stocks may not see a whole lot of growth next year.

2 Overrated Growth Stocks I'd Avoid in 2023

2 Canadian Marijuana Stocks To Know About In 2023 The post 2 Canadian Marijuana Stocks To Watch This Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Canadian Marijuana Stocks To Watch This Week

Investing in penny stocks does bring an element of nervousness. The stock price action can be unpredictable, particularly if we look at some purely speculative penny stocks.

3 No-Brainer Penny Stocks to Buy for 2023 and Beyond

LEAMINGTON, Ontario, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced that its medical cannabis division, Tilray Medical, has launched Take Back Control , a new platform developed to connect women with free resources on medical cannabis and to help destigmatize the use of medical cannabis in women's healthcare practices. The Take Back Control platform connects people with free consultations with healthcare practitioners focused on women's health providing expert advice on medical cannabis.

Tilray Launches ‘Take Back Control' Platform to Provide Women With Free Medical Cannabis Resources

Curaleaf Holdings, Inc.

If we look at the price action for cannabis stocks in the last five years, it's largely been disappointing. However, there have been two instances where cannabis stocks have skyrocketed in hopes of legalization.

3 Cannabis Stocks to Buy Before ‘Legalization' Sets Them Ablaze

Investors in these companies should be careful what they wish for.

Why Marijuana Legalization Could Be Bad News for Canopy Growth and Tilray Brands

What you need to know about buying marijuana penny stocks right now The post Marijuana Penny Stocks Buying Guide: Do's and Dont's  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Marijuana Penny Stocks Buying Guide: Do's and Dont's

Heron Therapeutics

Polestar Automotive Holding UK PLC

SNDL Inc.

Some good news is finally starting to creep into the markets with inflation easing in October. However, GDP growth remains a concern.

7 Penny Stocks to Buy for 10-Bagger Returns

Are Canadian Pot Stocks A Buy Now? The post Best Canadian Cannabis Stocks To Watch Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Canadian Cannabis Stocks To Watch Right Now

Blue Apron

3 Stocks to Sell ASAP Before They Implode

Marijuana legalization is coming, and marijuana investors like the sound of that.

Why Canopy Growth, Tilray, and Aurora Cannabis Stocks Glowed Green on Tuesday

It will need to see cannabis legalized in two major markets.

Here's How Tilray Could Grow by 3X Before 2027

One of these marijuana stocks is not like the others.

Why Aurora Cannabis and Tilray -- but Not Curaleaf -- Wilted on Monday

Buying marijuana penny stocks? 3 reasons to do so The post Are Marijuana Penny Stocks Worth Buying?

Are Marijuana Penny Stocks Worth Buying? 3 Reasons

Tilray Brands is positioning itself for cannabis legalization in the U.S. and the EU. Its faltering share of the Canadian adult-use market will make the next year or so difficult for investors.

Tilray Stock: Plenty Of Risk, Plenty Of Upside

Aurora Cannabis just reported a 28% decline in consumer marijuana sales -- and this is good news?

Why Aurora Cannabis, Canopy Growth, and Tilray Stocks Glowed Green on Friday

These beaten-down marijuana stocks are heating up today.

News for Tilray Brands Stock (TLRY)